(–)-Chaetominine
CAY-13135-500 500 µg
CAS
918659-56-0
Formulation
A solid
Purity
≥95%
MW
402,40288
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A cytotoxic alkaloid; inhibits the growth of K562 leukemia and SW1116 colon cancer cells (IC50s = 20 and 28 nM, respectively); induces apoptosis of K562 cells via upregulation of the Bax/Bcl-2 ratio, decreasing mitochondrial membrane potential, inducing cytochrome C release, and activation of caspase-3 and caspase-9; decreases MRP1-mediated doxorubicin efflux and restores sensitivity to doxorubicin in resistant K562 cells
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
